NBC NewsLean left
← All coverage gaps
2026-09-29 23:47
The right isn't covering this
Eli Lilly’s Experimental Weight-Loss Drug Shows Promising Results
100%
2 outlets · Left 2 · Center 0 · Right 0
How each side titled it
No right-side outlet ran this
Each wing's outermost outlet, headline quoted verbatim - framing shows clearest at the edges. Center outlets appear with every other headline below.
While the right was silent here, it led with…
- The Daily SignalRight
Senate Votes on Bill to End College Sports ‘Chaos’
11 right outlets ran this → - The BlazeRight
Trump launches new AI-powered website to streamline access to the federal government
10 right outlets ran this → - NewsmaxRight
Trump Announces New $15B Iowa Steel Plant and Claims it Will be Nation's Biggest - Newsmax
10 right outlets ran this →
The right's own top stories from this same window, ranked by how many of its outlets ran each one. Every headline is that side's own wording, quoted verbatim, and links to the story's full coverage here.
Who got there first
each line: one outlet's first article — above the track left · below right · across center
First reported by Time (Lean left); 2 outlets over 2 min.
Time · +2 min NBC News
What each side is saying
- NBC NewsLean left
Eli Lilly’s highly anticipated GLP-1 drug retatrutide helped people with Type 2 diabetes lose up to 60 pounds, or about 23% of their body weight, according to late-stage trial results published Tuesday in The Lancet.
Read at nbcnews.com → - TimeLean left
Two new studies on the experimental drug retatrutide show it helps overweight people lose weight, whether or not they have diabetes.
Read at time.com →
Each blurb is the outlet's own feed summary, quoted unedited. Nothing here is generated.
2 articles, newest first · filter by side
Every headline that clustered into this story, newest first. Links go straight to the publisher - no article text is stored here, and the one image is an unmodified copy of the publisher's own thumbnail.